Início › Leucemia Mieloide Aguda › Minnesota

Ensaios clínicos de Leucemia Mieloide Aguda em Minnesota

27 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Minnesota.

Cidades em Minnesota

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
e mais 48

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
e mais 8

RecrutandoFase 2

Idades de 18 a 59 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
e mais 8

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

University of Minnesota/Masonic Cancer Center, Minneapolis

RecrutandoFase 1

Até 21 anos · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07012044

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
e mais 8

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
e mais 8

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
e mais 9

RecrutandoFase 2

Idades de 18 a 59 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
University of Minnesota/Masonic Cancer Center, Minneapolis
Mayo Clinic in Rochester, Rochester

RecrutandoFase 3

6 Months – 21 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04293562

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Mayo Clinic, Rochester

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT04588922

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

US-Rochester MN-MAYOMN, Rochester

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06652438

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
University of Minnesota/Masonic Cancer Center, Minneapolis
Mayo Clinic in Rochester, Rochester

RecrutandoFase 1/2

Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Masonic Cancer Center, Minneapolis

RecrutandoFase 3

29 Days – 21 Years · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of Minnesota, Minneapolis

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07007312

Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)

Masonic Cancer Center, Minneapolis

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07008638

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

Masonic Cancer Center, Minneapolis

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT06594445

Allo HSCT Using RIC and PTCy for Hematological Diseases

Masonic Cancer Center at University of Minnesota, Minneapolis

RecrutandoFase 2

Até 75 anos · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT05805605

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Masonic Cancer Center at University of Minnesota, Minneapolis

RecrutandoFase 2

Até 60 anos · Todos os sexos · Atualizado em 25 de jun. de 2026 · NCT03314974

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Mayo Clinic in Rochester, Rochester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT03017820

Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT

Mark Juckett, MD, Minneapolis

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de mai. de 2026 · NCT07591649

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

Masonic Cancer Center at University of Minnesota, Minneapolis

RecrutandoFase 2

Idades de 2 a 75 · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT07493538

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Mayo Clinic Comprehensive Cancer Center, Rochester

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT05732103

Backtracking Leukemia-Typical Somatic Mutations in Cord Blood

University of Minnesota/Masonic Cancer Center, Minneapolis

RecrutandoEstudo observacional

Até 25 anos · Todos os sexos · Atualizado em 8 de abr. de 2026 · NCT05014165

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

University of Minnesota Masonic Cancer Center, Minneapolis

RecrutandoFase 2

Até 60 anos · Todos os sexos · Atualizado em 6 de abr. de 2026 · NCT05735717

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Mayo Clinic in Rochester, Rochester

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 1 de abr. de 2026 · NCT06279572

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

University of Minnesota, Minneapolis
Mayo Clinic - Rochester, Rochester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de mar. de 2026 · NCT05735184

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Mayo Clinic, Rochester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de fev. de 2026 · NCT06950034

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Mayo Clinic, Rochester

RecrutandoVoluntários saudáveis bem-vindos

Idades de 18 a 120 · Todos os sexos · Atualizado em 25 de jul. de 2025 · NCT05237258

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.